Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 24ASTRAZENECA AB

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EXENATIDE SYNTHETIC

US Patent Number : 8906851

Drug Substance Claim :

Drug Product Claim :

Application Number : 209210

Patent Use Code : U-3190

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-18

blank

02

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EXENATIDE SYNTHETIC

US Patent Number : 8906851

Drug Substance Claim :

Drug Product Claim :

Application Number : 22200

Patent Use Code : U-3188

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-18

blank

03

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EXENATIDE SYNTHETIC

US Patent Number : 8906851

Drug Substance Claim :

Drug Product Claim :

Application Number : 209210

Patent Use Code : U-2597

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-18

blank

04

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EXENATIDE SYNTHETIC

US Patent Number : 8906851

Drug Substance Claim :

Drug Product Claim :

Application Number : 209210

Patent Use Code : U-3188

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-18

blank

05

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

DAPAGLIFLOZIN

US Patent Number : 8906851

Drug Substance Claim :

Drug Product Claim :

Application Number : 202293

Patent Use Code : U-2139

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-18

blank

06

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EXENATIDE SYNTHETIC

US Patent Number : 8906851

Drug Substance Claim :

Drug Product Claim :

Application Number : 209210

Patent Use Code : U-2589

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-18

blank

07

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EXENATIDE SYNTHETIC

US Patent Number : 8906851

Drug Substance Claim :

Drug Product Claim :

Application Number : 22200

Patent Use Code : U-2590

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-18

blank

08

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EXENATIDE SYNTHETIC

US Patent Number : 8906851

Drug Substance Claim :

Drug Product Claim :

Application Number : 22200

Patent Use Code : U-2590

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-18

blank

09

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EXENATIDE SYNTHETIC

US Patent Number : 8906851

Drug Substance Claim :

Drug Product Claim :

Application Number : 22200

Patent Use Code : U-3190

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-18

blank

10

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

EXENATIDE SYNTHETIC

US Patent Number : 8906851

Drug Substance Claim :

Drug Product Claim :

Application Number : 22200

Patent Use Code : U-3188

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-18

blank